1. Home
  2. PLSM vs CYCN Comparison

PLSM vs CYCN Comparison

Compare PLSM & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulsenmore Ltd. Ordinary Shares

PLSM

Pulsenmore Ltd. Ordinary Shares

N/A

Current Price

$2.22

Market Cap

15.7M

Sector

Health Care

ML Signal

N/A

Logo Cyclerion Therapeutics Inc.

CYCN

Cyclerion Therapeutics Inc.

HOLD

Current Price

$23.52

Market Cap

16.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLSM
CYCN
Founded
2014
2018
Country
Israel
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.7M
16.6M
IPO Year
2025
2019

Fundamental Metrics

Financial Performance
Metric
PLSM
CYCN
Price
$2.22
$23.52
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
44.8K
114.2K
Earning Date
03-30-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
8.26
EPS
N/A
N/A
Revenue
N/A
$2,074,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.70
52 Week Low
$2.26
$1.03
52 Week High
$12.97
$8.48

Technical Indicators

Market Signals
Indicator
PLSM
CYCN
Relative Strength Index (RSI) 31.47 41.06
Support Level N/A $3.04
Resistance Level $2.88 $3.42
Average True Range (ATR) 0.24 0.49
MACD 0.02 -0.03
Stochastic Oscillator 19.35 23.67

Price Performance

Historical Comparison
PLSM
CYCN

About PLSM Pulsenmore Ltd. Ordinary Shares

Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.

Share on Social Networks: